Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon

Bulletin of the World Health Organization

Volumn 80, Issue 7, 2002, Pages 538-545

  Basco, Leonardo K ^a   Same Ekobo, Albert ^a,b   Ngane, Vincent Foumane ^c,d   Ndounga, Mathieu ^d,e,f,g   Metoh, Theresia ^d,f,g   Ringwald, Pascal ^d,f,g   Soula, Georges ^d,e,f,g  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c MINISTRY OF PUBLIC HEALTH   (Cameroon)

^d Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

^e Centre d'Études Sur Les Ressources Végétales   (Congo)

^f UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Amodiaquine therapeutic use administration and dosage; Drug combinations pharmacology; Drug resistance; Malaria, Falciparum drug therapy; Pyrimethamine therapeutic use administration and dosage; Sulfadoxine therapeutic use administration and dosage

Indexed keywords

AMODIAQUINE; ARTEMISIN DERIVATIVE; FANSIDAR; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

DISEASE TREATMENT; DRUG PRESCRIBING; HEALTH MONITORING; MALARIA;

ANEMIA; ARTICLE; CAMEROON; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEVER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT FAILURE; BLOOD; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG MONITORING; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HEMATOCRIT; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PARASITOLOGY; PRESCHOOL CHILD; TIME; TREATMENT OUTCOME;

CAMEROON;

ADMINISTRATION, ORAL; AMODIAQUINE; ANTIMALARIALS; CAMEROON; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG MONITORING; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; MALARIA, FALCIPARUM; MALE; PARASITIC SENSITIVITY TESTS; PYRIMETHAMINE; SULFADOXINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036316594     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa
2. Chemoresistance of Plasmodium falciparum in urban areas of Yaoundè, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaoundé, Cameroon
3. Evaluation of the resistance of Plasmodium falciparum to chloroquine in Cameroon and alternative therapies
4. Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children
5. Making malaria-treatment policy in the face of drug resistance
6. Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania
7. Chemoresistance of Plasmodium falciparum in the urban areas of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon
8. A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya
9. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulpha-doxine in Gambian children with uncomplicated malaria
10. Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age
11. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa
12. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone
13. Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania
14. Efficacy of sulfadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old
15. The dynamics of drug resistance in Plasmodium falciparum
16. Plasmodium falciparum: Sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar
17. The mechanisms of drug action and resistance in malaria
18. Systematic review of amodiaquine treatment in uncomplicated malaria
19. Amodiaquine-resistant falciparum in Thailand
20. Amodiaquine fails to cure chloroquine-resistant Plasmodium falciparum in the Punjab
21. Ineffectiveness of amodiaquine against Plasmodium falciparum malaria in symptomatic young children living in an endemic malarious area of Papua New Guinea
22. Chloroquine versus amodiaquine in the treatment of Plasmodium falciparum malaria in northeast India
23. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya
24. The prevention of antimalarial drug resistance
25. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
26. Combination chemotherapy for Plasmodium falciparum malaria
27. Severe falciparum malaria
28. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique
29. Comparative study of the efficacy and side-effects of two therapeutic regimens against chloroquine-resistant falciparum malaria in Maputo, Mozambique
30. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China
31. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria: A systematic review